Rankings
▼
Calendar
ANIK Q2 2021 Earnings — Anika Therapeutics, Inc. Revenue & Financial Results | Market Cap Arena
ANIK
Anika Therapeutics, Inc.
$208M
Q2 2021 Earnings
Healthcare
Medical - Devices
Income Statement
Revenue
$38M
+24.3% YoY
Gross Profit
$21M
54.6% margin
Operating Income
$9M
24.1% margin
Net Income
$7M
17.1% margin
EPS (Diluted)
$0.45
QoQ Revenue Growth
+11.2%
Cash Flow
Operating Cash Flow
$4M
Free Cash Flow
$2M
Stock-Based Comp.
$0
Balance Sheet
Total Assets
$363M
Total Liabilities
$76M
Stockholders' Equity
$287M
Cash & Equivalents
$97M
Year-over-Year Comparison
Metric
Current
Year Ago
Change
Revenue
$38M
$31M
+24.3%
Gross Profit
$21M
$14M
+51.4%
Operating Income
$9M
-$10M
+196.3%
Net Income
$7M
-$8M
+184.7%
Revenue Segments
Product
$38M
50%
Joint Pain Management Therapies
$24M
32%
Joint Preservation and Restoration
$12M
16%
Manufactured Product, Other
$2M
3%
Geographic Segments
UNITED STATES
$30M
86%
Europe
$5M
14%
← FY 2021
All Quarters
Q3 2021 →